lanthanum carbonate has been researched along with dapagliflozin in 1 studies
Studies (lanthanum carbonate) | Trials (lanthanum carbonate) | Recent Studies (post-2010) (lanthanum carbonate) | Studies (dapagliflozin) | Trials (dapagliflozin) | Recent Studies (post-2010) (dapagliflozin) |
---|---|---|---|---|---|
390 | 87 | 218 | 1,478 | 368 | 1,407 |
Protein | Taxonomy | lanthanum carbonate (IC50) | dapagliflozin (IC50) |
---|---|---|---|
Sodium/glucose cotransporter 1 | Homo sapiens (human) | 1.1661 | |
Sodium/glucose cotransporter 2 | Homo sapiens (human) | 0.0022 | |
Sodium/myo-inositol cotransporter 2 | Homo sapiens (human) | 0.38 | |
Solute carrier family 5 member 4 | Homo sapiens (human) | 0.0014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gregus, Z; Németi, B; Poór, M | 1 |
1 other study(ies) available for lanthanum carbonate and dapagliflozin
Article | Year |
---|---|
Effects of phosphate binders on the gastrointestinal absorption of arsenate and of an SGLT2 inhibitor drug on the urinary excretion of arsenite in mice.
Topics: Aluminum Hydroxide; Animals; Arsenates; Arsenites; Benzhydryl Compounds; Female; Gastrointestinal Absorption; Glucosides; Kidney; Lanthanum; Liver; Mice; Phosphates; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |